This page provides educational resources, events, news and products related to anticancer therapies. Content will cover aspects from chemo- and radiotherapies, to cell-based treatments and cancer vaccines.
Anticancer Therapies – Highlights
Cancer Drug Discovery: A Molecular Journey to Targeted Treatment
Cancer drug discovery has made great advances since its earliest steps. Cytotoxic drugs affect healthy cells, as well as the tumor, and thus give rise to a multitude of side effects. To counter this, the focus has shifted to targeted approaches that exploit molecular characteristics that are unique to the tumor.
Milestones in Cancer Drug Discovery
Download this infographic to explore major cancer drug discovery milestones throughout history and the five pillars of modern-day cancer treatment.
New Advances in Cancer Drug Discovery
Download this listicle to discover new biological insights, explore various drug modalities and uncover novel drug combinations.
New Method Provides a 3D Map of Cells' Activities
A new method has been developed that enables analysis of the spatial patterns of gene expression in three dimensions, permitting greater understanding of how a cell's environment can impact gene expression.
Re-Educating the Immune Response To Treat Type 1 Diabetes
CAR T-cell therapy is largely used to treat cancers, but here we explore how Dr. Leonardo Ferreira and his team are using CAR T-cell therapy to treat Type 1 diabetes.
Solid Tumors Use T Cells as a Shield Against Immune Attack
Researchers have discovered that solid tumors misuse a type of T cell, which protects them from the immune system.
Targeted Drug Delivery Systems Designed From Llama Nanobodies
Researchers at Johns Hopkins Medicine have designed nanobodies from llama antibodies that could be used to deliver medicines to human muscle cells.
Research Tools for Anti-Cancer Drug Targets
Currently, various treatments are available to cancer patients, such as chemotherapy, targeted therapy and immunotherapy. Targeted therapy is a type of precision medicine that targets the proteins that control the growth, division and spread of cancer cells.
Protein Biomarkers Show Promise in Predicting Patient Response to Cancer Immunotherapies
Cancer immunotherapy relies on activating or enhancing the antitumor immune response and has taken a central position in cancer treatment modalities. However, not all patients respond to immunotherapy, and combination immunotherapies increase cost of treatment and heighten the risk for toxicity-related adverse events.